Drug Shortage Report for ACETAMINOPHEN, CAFFEINE & CODEINE
| Report ID | 43848 |
| Drug Identification Number | 02028174 |
| Brand name | ACETAMINOPHEN, CAFFEINE & CODEINE |
| Common or Proper name | ACET CODEINE |
| Company Name | PHARMASCIENCE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ACETAMINOPHEN CODEINE PHOSPHATE CAFFEINE |
| Strength(s) | 300MG 8MG 15MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N02AJ |
| ATC description | OPIOIDS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2018-03-23 |
| Estimated end date | Unknown |
| Actual end date | 2020-06-05 |
| Shortage status | Resolved |
| Updated date | 2020-06-09 |
| Company comments | in process of deactivation Product already discontinued DIN cancelled post market. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-06-09 | French | Compare |
| v4 | 2020-06-09 | English | Compare |
| v3 | 2018-03-24 | English | Compare |
| v2 | 2018-03-23 | French | Compare |
| v1 | 2018-03-23 | English | Compare |
Showing 1 to 5 of 5